FDA Inspection 1232642 — Transfusion Medicine Department Temple University Hospital
The FDA completed an inspection of Transfusion Medicine Department Temple University Hospital on Feb 23, 2024 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 23, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Philadelphia, PA (United States)